SP1 and cardiac hypertrophy: Research indicates that SP1-induced SNHG14 aggravates cardiac hypertrophy by sponging miR-322-5p and miR-384-5p to upregulate protocadherin 17 (PCDH17), making SNHG14 a potential biomarker for cardiac hypertrophy (68).